Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

2007

Annual report for the year ended 30 June 2007

1 May 201313 September 2007 by Karen Mobbs

Annual report for the year ended 30 June 2007

Categories 2007, Annual Reports

Notice of Annual General Meeting

1 May 20133 September 2007 by Karen Mobbs

Notice of Annual General Meeting

Categories 2007

BIT225 Phase I Clinical Trial Successfully Completed

1 May 201316 August 2007 by Karen Mobbs

BIT225 Phase I Clinical Trial Successfully Completed

Categories 2007

Response to ASX query

1 May 20137 August 2007 by Karen Mobbs

Response to ASX query

Categories 2007

BIT225 Highly Synergistic with Current Anti-Hepatitis C Virus Therapies

1 May 20137 August 2007 by Karen Mobbs

BIT225 Highly Synergistic with Current Anti-Hepatitis C Virus Therapies

Categories 2007

Quarterly Report 30 June 2007

1 May 201330 July 2007 by Karen Mobbs

Quarterly Report 30 June 2007

Categories 2007, Quarterly Reports

HIV Drug Data Presented at International Conference

1 May 201325 July 2007 by Karen Mobbs

HIV Drug Data Presented at International Conference

Categories 2007

Expansion of Biotron Antiviral Program to Hepatitis B Virus and Phase I Trial Update

1 May 201310 July 2007 by Karen Mobbs

Expansion of Biotron Antiviral Program to Hepatitis B Virus and Phase I Trial Update

Categories 2007

Quarterly Report 31 March 2007

1 May 201323 April 2007 by Karen Mobbs

Quarterly Report 31 March 2007

Categories 2007, Quarterly Reports

Biotron Begins Phase I Clinical Trial of its HIV Drug BIT225

1 May 201322 March 2007 by Karen Mobbs

Biotron Begins Phase I Clinical Trial of its HIV Drug BIT225

Categories 2007
Older posts
Newer posts
← Previous Page1 Page2 Page3 Next →
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 25 June 2025        Legal Notices and Privacy
Cleantalk Pixel